4//SEC Filing
HORGAN KEVIN 4
Accession 0000899243-19-002142
CIK 0001609809other
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 6:55 PM ET
Size
5.5 KB
Accession
0000899243-19-002142
Insider Transaction Report
Form 4
HORGAN KEVIN
Chief Medical Officer and EVP
Transactions
- Award
STOCK OPTION (RIGHT TO BUY)
2019-01-25+30,000→ 30,000 totalExercise: $6.01Exp: 2029-01-24→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option will vest as to 25% of the shares on January 25, 2020. The remainder of the shares will vest in 12 equal quarterly installments thereafter.
Documents
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeother
Related Parties
1- filerCIK 0001510614
Filing Metadata
- Form type
- 4
- Filed
- Jan 28, 7:00 PM ET
- Accepted
- Jan 29, 6:55 PM ET
- Size
- 5.5 KB